Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.

MLA

Boyd, Anders, et al. “Hepatitis B Surface Antigen Quantification as a Predictor of Seroclearance during Treatment in HIV-Hepatitis B Virus Coinfected Patients from Sub-Saharan Africa.” Journal of Gastroenterology and Hepatology, vol. 31, no. 3, Mar. 2016, pp. 634–44. EBSCOhost, https://doi.org/10.1111/jgh.13156.

APA

Boyd, A., Maylin, S., Moh, R., Mahjoub, N., Gabillard, D., Eholié, S. P., Danel, C., Anglaret, X., Zoulim, F., Girard, P.-M., Delaugerre, C., & Lacombefor, K. (2016). Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa. Journal of Gastroenterology and Hepatology, 31(3), 634–644. https://doi.org/10.1111/jgh.13156

Chicago

Boyd, Anders, Sarah Maylin, Raoul Moh, Nadia Mahjoub, Delphine Gabillard, Serge Paul Eholié, Christine Danel, et al. 2016. “Hepatitis B Surface Antigen Quantification as a Predictor of Seroclearance during Treatment in HIV-Hepatitis B Virus Coinfected Patients from Sub-Saharan Africa.” Journal of Gastroenterology and Hepatology 31 (3): 634–44. doi:10.1111/jgh.13156.